CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review. [PDF]
João RB +3 more
europepmc +1 more source
Causal effects of lipid-lowering drug targets on psychiatric disorders: A drug-target Mendelian randomization study. [PDF]
Wang Y, Liu X, Huang S.
europepmc +1 more source
Emerging insights into the role of BDH1 in the pathogenesis of human cancer. [PDF]
Wang P, Yan Y, Liu Z, Feng G, Yu W.
europepmc +1 more source
Perspectives on Bempedoic Acid, ATP-citrate lyase inhibitor: Targeting Lipid Metabolism and Inflammation. [PDF]
Kitamoto R +2 more
europepmc +1 more source
Skeletal muscle-specific deficiency of Rab geranylgeranyl transferase beta subunit induces myopathy and exacerbates the symptoms caused by HMG-CoA reductase deficiency in mice. [PDF]
Osaki Y +16 more
europepmc +1 more source
Statins Safety Signals: From Precautions to Proportionate Evidence-Based Labeling. [PDF]
Locquet M +3 more
europepmc +1 more source
HMGCR genetic variation and risk of new-onset type 2 diabetes in statin users. [PDF]
Albawa'neh AS +9 more
europepmc +1 more source
Statins and Fibrates in Age-Related Macular Degeneration: A Contemporary Clinical Narrative Review (2020-2025). [PDF]
Dmoch W +5 more
europepmc +1 more source
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin. [PDF]
Levomäki R +3 more
europepmc +1 more source
Computational Evaluation of Statin Analogs Targeting HMG-CoA Reductase for Coronary Artery Disease Treatment. [PDF]
Mtulo YB +4 more
europepmc +1 more source

